Literature DB >> 12904371

Epidemiology and outcome of nosocomial and community-onset bloodstream infection.

D J Diekema1, S E Beekmann, K C Chapin, K A Morel, E Munson, G V Doern.   

Abstract

We performed a prospective study of bloodstream infection to determine factors independently associated with mortality. Between February 1999 and July 2000, 929 consecutive episodes of bloodstream infection at two tertiary care centers were studied. An ICD-9-based Charlson Index was used to adjust for underlying illness. Crude mortality was 24% (14% for community-onset versus 34% for nosocomial bloodstream infections). Mortality attributed to the bloodstream infection was 17% overall (10% for community-onset versus 23% for nosocomial bloodstream infections). Multivariate logistic regression revealed the independent associations with in-hospital mortality to be as follows: nosocomial acquisition (odds ratio [OR] 2.6, P < 0.0001), hypotension (OR 2.6, P < 0.0001), absence of a febrile response (P = 0.003), tachypnea (OR 1.9, P = 0.001), leukopenia or leukocytosis (total white blood cell count of <4500 or >20000, P = 0.003), presence of a central venous catheter (OR 2.0, P = 0.0002), and presence of anaerobic organism (OR 2.5, P = 0.04). Even after adjustments were made for underlying illness and length of stay, nosocomial status of bloodstream infection was strongly associated with increased total hospital charges (P < 0.0001). Although accounting for about half of all bloodstream infections, nosocomial bloodstream infections account for most of the mortality and costs associated with bloodstream infection.

Entities:  

Mesh:

Year:  2003        PMID: 12904371      PMCID: PMC179863          DOI: 10.1128/JCM.41.8.3655-3660.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.

Authors:  S K Fridkin; C D Steward; J R Edwards; E R Pryor; J E McGowan; L K Archibald; R P Gaynes; F C Tenover
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay.

Authors:  M A Martin; M A Pfaller; R P Wenzel
Journal:  Ann Intern Med       Date:  1989-01-01       Impact factor: 25.391

3.  A three-year study of positive blood cultures, with emphasis on prognosis.

Authors:  F J Roberts; I W Geere; A Coldman
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

4.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

5.  Septic shock in bacteremic patients: risk factors, features and prognosis.

Authors:  L Leibovici; M Drucker; H Konigsberger; Z Samra; S Harrari; S Ashkenazi; S D Pitlik
Journal:  Scand J Infect Dis       Date:  1997

6.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

7.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

Authors:  J Gómez; V Baños; J Ruiz; F Herrero; M Pérez; L Pretel; M Canteras; M Valdés
Journal:  Clin Investig       Date:  1993-08

Review 9.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

10.  Clinical significance and outcome of anaerobic bacteremia.

Authors:  J H Salonen; E Eerola; O Meurman
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more
  83 in total

1.  A Systematic Review and Meta-analysis of Antibiotic Treatment Duration for Bacteremia Due to Enterobacteriaceae.

Authors:  Giannoula S Tansarli; Nikolaos Andreatos; Elina E Pliakos; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

3.  DNA microarray genotyping and virulence and antimicrobial resistance gene profiling of methicillin-resistant Staphylococcus aureus bloodstream isolates from renal patients.

Authors:  Sinead McNicholas; Anna C Shore; David C Coleman; Hilary Humphreys; Deirdre Fitzgerald Hughes
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection.

Authors:  M N Al-Hasan; J E Eckel-Passow; L M Baddour
Journal:  Epidemiol Infect       Date:  2011-02-01       Impact factor: 2.451

5.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

6.  Species-driven interpretation guidelines in case of a single-sampling strategy for blood culture.

Authors:  D Leyssene; S Gardes; P Vilquin; J-P Flandrois; G Carret; B Lamy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

7.  Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections.

Authors:  Caitlin M Wolfe; Bevin Cohen; Elaine Larson
Journal:  J Infect Public Health       Date:  2014-03-13       Impact factor: 3.718

8.  The Lung is a Host Defense Niche for Immediate Neutrophil-Mediated Vascular Protection.

Authors:  Bryan G Yipp; Jung Hwan Kim; Ronald Lima; Lori D Zbytnuik; Björn Petri; Nick Swanlund; May Ho; Vivian G Szeto; Tamar Tak; Leo Koenderman; Peter Pickkers; Anton T J Tool; Taco W Kuijpers; Timo K van den Berg; Mark R Looney; Matthew F Krummel; Paul Kubes
Journal:  Sci Immunol       Date:  2017-04-28

9.  Long-term mortality associated with community-onset bloodstream infection.

Authors:  K B Laupland; L W Svenson; D B Gregson; D L Church
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

10.  Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.

Authors:  Jonas Marschall; Denis Agniel; Victoria J Fraser; Joshua Doherty; David K Warren
Journal:  J Antimicrob Chemother       Date:  2008-03-15       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.